drugset / Trial / NCT00992797

Diabetes Intervention Trial With Vitamin D in Subjects of Nordic and Sub-Indian Ethnicity

NCT00992797

RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this 6 months study is to evaluate the metabolic effects of 400.000-600.000 IU of vitamin D supplementation in subjects with type 2 diabetes and hypovitaminosis D. The main hypothesis is that subjects with low levels of 25-OH-vitamin D will benefit from supplementation with cholecalciferol in sufficient doses to optimize serum levels.

Timeline

Start
2009-09
Primary completion
2010-12
Completion
2011-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Cholecalciferol Other / unclassified 200000 iu Oral
Subject Cholecalciferol Other / unclassified 400000 iu Oral